Please wait a minute...
Office
期刊信息
  • 临床肿瘤学杂志
    主管:解放军无锡联勤保障中心
    主办:解放军东部战区总医院
    编辑出版:临床肿瘤学杂志编辑部
    主编:秦叔逵
    编辑部主任:龚新雷
    地址:南京市杨公井34标34号
    邮编:210002
    电话:(025)84400143;80864363
    E-mail: lczlx@vip.163.com
    邮发代号:28-267
    刊期:月刊
    定价:每期15元,全年180元
    标准刊号: ISSN 1009-0460
    CN 32-1577/R
     
Table of Content
30 June 2015, Volume 20 Issue 6
论著
Inhibitory effect of formononetin on proliferation and epithelial mesenchymal transition of non-small cell lung cancer A549 cells
LI Aiming, ZHAO Huimin, JIE Junqing.
Chinese Clinical Oncology. 2015, 20 (6):  481. 
Abstract ( 878 )   PDF(pc) (1532KB) ( 400 )   Save
Objective To explore the inhibitory effect of formononetin (Form) on proliferation and epithelial mesenchymal transition (EMT) of non-small cell lung cancer A549 cells. Methods The A549 cells were cultured with Form (a final concentration of 0.1, 1, 10, 100 μmol/L). The cell proliferation was determined at 24, 48, 72 and 96 h posttreatment by MTT method in control group and From group. The Annexin V-FITC/PI double staining combined with flow cytometry and quantitative realtimepolymerase chain reaction were applied to measure the early-apoptotic and late-apoptotic rates and expression of apoptosis related genes at 48 h after treatment. Western blotting was used to detect the EMT related molecular markers, including E-cadherin, N-cadherin and Vimentin. The supernatant levels of fibronectin (FN) were measured at 24, 48, 72 and 96 h by enzyme linked immunosorbent assay. Results Form exerted the inhibitory effect on the proliferation of A549 cells in the range of 1-100 mol/L, and presented in a dose- and time-dependent manner. In addition to 0.1 mol/L at 24-48 h, the proliferation inhibiting rates of Form were higher than those of control group (P<0.05). Compared with the control group, there were higher levels of early-apoptotic and late-apoptotic rates and mRNA levels of Bax and Bak but lower Bcl-2 mRNA levels in Form groups with statistical significance (P<0.05). In response to Form, there were increased E-cadherin but decreased N-cadherin, Vimentin and FN in comparison with control group at 48 h. Conclusion Form has a toxic effect on A549, which not only inhibit the proliferation and induce apoptosis. It may be related to the inhibition of the EMT process.
Related Articles | Metrics
Expression and function of AKR1C1 in non-small cell lung cancer

TIAN He, JIANG Wenli, LOU Guoliang, HUANG Caiguo, CHEN Ruohua.

Chinese Clinical Oncology. 2015, 20 (6):  487. 
Abstract ( 799 )   PDF(pc) (3166KB) ( 345 )   Save
Objective To investigate the expression and clinical significance of AKR1C1 in non-small cell lung cancer(NSCLC) tissues and cell line. Methods Immunohistochemical SP method was used to examine the expression of AKR1C1 in 50 cases of NSCLC tissues and matched adjacent normal tissues. NCI-H460 cell was transfected with AKR1C1 siRNA(AKR1C1 interference group) and AKR1C1 negative control siRNA(negative control group). Western blotting was used to confirm the results of transfection. The proliferation, colony formation and invasion ability were analyzed by MTT, low-density cell colony formation, woundinghealing and transwell experiments. The blank control group was set. Results The high-level expression rates of AKR1C1 in cancer tissues were 94.0%(47/50), which was higher than 6.0%(3/50)in matched adjacent normal tissues (P<0.05). MTT analysis showed the proliferation rate of AKR1C1 interference group and negative control group was the same. The colony formation number of AKR1C1 interference group, negative control group and blank control group were 69.60±4.03, 69.00±1.63 and 70.33±2.05, with no significant difference. The number of migrated cells in AKR1C1 interference group was 15.30±2.50, which was lower than that of negative control group (30.00±2.20) and blank control group (31.30±2.40),with significant differences(P<0.05). The relative migrated distance of the cells in AKR1C1 interference group was 0.13±0.05, which was lower than that negative control group (0.60±0.08)and blank control group(0.56±0.05),with significant differences(P<0.05). Conclusion AKR1C1 is high expressed and may relate to the migration in NSCLC.
Related Articles | Metrics
The effect of gold nanoparticles on increasing radiosensitivity of SPC-A1 lung cancer cell in vitro
XU Guoping,YAO Zhifeng,YANG Hang,LIU Yongbiao.
Chinese Clinical Oncology. 2015, 20 (6):  492. 
Abstract ( 892 )   PDF(pc) (1296KB) ( 319 )   Save

Objective To observe the radiosensitizing effect of gold nanoparticles(AuNPs) on SPC-A1 lung cancer cell line of megavoltage ray radiation therapy and probe its radiosesitizing mechanisms in vitro.
Methods SPC-A1 cells were cultured in vitro. The cytotoxicity effect of different concentrations of AuNPs(0, 1, 0.5, 0.25, 0.125,0.0625 mmol/L) on SPC-A1 cells were measured by CCK-8 at 24, 48 and 72 h after treatment. The experimental concentration of AuNPs was determined according to CCK-8 method. SPC-A1 cells were processed with different doses of 6MV X-ray and 4MeV electron beam including 0, 1, 2, 4, 6, 8 Gy alone or together with AuNPs(0.25 mmol/L)). The cell survival faction(SF) was evaluated by using a standard colonyforming assay. Cell cycle distribution and apoptosis of different groups were detected at 24 h after treatment with AuNPs(0.25 mmol/L) by flow cytometry assay. Results Cell viability test showed the proliferation of SPC-A1 cells was not significantly inhibited after treatment with different concentrations of AuNPs at different points of time, and had no effect on the time and concentration. The initial concentration of AuNPs(0.25 mmol/L)) was used as the concentration of the experiment. The enhanced radiosensitivity of SPC-A1 lung cancer cells has been observed. The sensitivity enhancement ratio(SER) at 37% survival level were 1.111 and 1.214 at 24 h after treatment of AuNPs combined with 6MV Xray and 4MeV electron beam repectively. Flow cytometry showed that cell apoptosis was not increased by individual AuNPs, but the rays on cell apoptosis was significantly increased. The cell cycle detection showed that the cell cycle was accelerated at the G0/G1 phase, and arrested at the G2/M phase after the treatment with AuNPs. Conclusion AuNPs can be used for the enhancement of radiation effects on SPC-A1 lung cancer cells of megavoltage X-ray radiation therapy and electron radiation therapy beams. Its mechanism may relate to increase apoptosis and cell cycle synchronization.

Related Articles | Metrics
The impact on the biological function of gastric cancer cell with down-regulating expression of ALDH1A1

WU Chengli,YU Xihao,WANG Yongmei, WANG Gefang, YU Guanzhen, WANG Jiejun.

Chinese Clinical Oncology. 2015, 20 (6):  497. 
Abstract ( 801 )   PDF(pc) (952KB) ( 372 )   Save
Objective To evaluate the effect of ALDH1A1 silence on the proliferation, clone formation and invasion of human gastric cancer cell lines. Methods The siRNA expression vector, PGPU6/GFP/Neo-ALDH1A1,targeting ALDH1A1 were constructed and transfected the gastric cancer cell line MKN-45 cells. The MKN-45 cells were divided into siRNA group(negative group),PGPU6/GFP/Neo-group(experimental group) and blank control group. After transfection, the protein expression of ALDH1A1 was detected by the Western blotting assay. The MTT assay, the colony forming unit assay and the transwell test were performed to detect proliferation, colony forming and invasion of MKN-45 cells through down-regulating expression of ALDH1A1. Results The level of protein expression of ALDH1A1 in experimental group was significantly decreased than negative group(0.36±0.04 vs. 0.72±0.08,P<0.05).Compared with negative group, the proliferation inhibitory of MKN-45 cells were obviously increased in experimental group[(52.56±1.81) vs. (30.32±2.23),P<0.05]; the colony forming unit of MKN-45 cells in experimental group was obviously reduced(21.67±2.00 vs. 36.78±3.53,P<0.05); the invasion MKN-45 cells in experimental group was obviously reduced (55.11±7.98 vs. 84.78±6.00,P<0.05).Conclusion Down-regulating the expression of ALDH1A1 in gastric cancer cell line MKN-45 by siRNA interference, ALDH1A1 can inhibit the proliferation,colony forming and invasion of human gastric cancer cell MKN-45. ALDH1A1 is a potential target for treating gastric cancer.
Related Articles | Metrics
Effects of BRD4 inhibitor on proliferation, apoptosis and invasion of nasopharyngeal carcinoma cell line CNE-2
LIU Zhong, YANG Fei, CHENG Ji, TIAN Tianjie.
Chinese Clinical Oncology. 2015, 20 (6):  501. 
Abstract ( 777 )   PDF(pc) (1588KB) ( 349 )   Save
Objective To explore the effects of bromodomain-containing protein 4 (BRD4) inhibitor(GSK525762A) on proliferation, apoptosis and invasion of nasopharyngeal carcinoma cell line CNE-2. Methods The nasopharyngeal carcinoma cell line CNE-2 was treated by GSK525762A (0, 0.1, 1, 10, 100 μmol/L) for 24, 48, 72 and 96 h. The methyl thiazolyl tetrazolium salt (MTT) was used to detect the proliferation inhibition rates at the above time points. Meanwhile, the apoptotic rates of CNE-2 cells at 48, 96 h after treatment with GSK525762A were measured with Annexin-FITC/PI double staining via flow cytometry. Transwell method was used to detect the invasion ability of CNE-2 cells at 48, 96 h after treatment with GSK525762A. The realtime quantitative PCR was performed to detect expressions of apoptosis related genes at 48, 96 h after treatment with GSK525762A. Results There was inhibitory effect of GSK525762A on the proliferation of CNE-2 cells, and the inhibition rate was increased in a time- and concentration-dependent manner (P<0.05). After the treatment of GSK525762A, the early, late and total apoptotic rates increased with the increase of concentrations, higher than those of 0 mol/L group (P<0.05); the number of transmembrane cells of other concentrations were lower than that of 0 mol/L group (P<0.05); Compared with the 0 μmol/L, there were lower level of mRNA in Bcl-2 but higher levels of mRNA in Bax and Bak with the range (0.1-100 μmol/L) (P<0.05). Conclusion BRD4 inhibitor GSK525762A presented toxicity on the proliferation of CNE-2 cell, induced apoptosis and restored the expressions of apoptosis related genes.
Related Articles | Metrics
Study on P16INK4A, Brn-3a, C-myc and telomerase in early diagnosis of cervical carcinoma

SHI Haofan, LI Zhen, TAN Ji.

Chinese Clinical Oncology. 2015, 20 (6):  506. 
Abstract ( 698 )   PDF(pc) (808KB) ( 339 )   Save
Objective To explore the value of gene expression of P16INK4A, Brn-3a and C-myc as well as the activity of telomerase in diagnosis of cervical carcinoma. Methods Cancer tissues from 40 cases of cervical cancer undergoing surgical treatment in our hospital from 2012 March to 2014 May were collected for the detection of P16INK4A, Brn-3a, C-myc and telomerase. Meanwhile, cervical tissues from 28 cases of normal cervical patients and 40 cases of cervical intraepithelial neoplasia were chosen for comparison. The receiver operating characteristic curve (ROC) was employed to evaluate the diagnostic value of gene expression of P16INK4A, Brn-3a and C-myc as well as the activity of telomerase on cervical carcinoma. Results The positive expression rates of P16INK4A, Brn-3a and C-myc were 100.0%, 95.0% and 100.0% in cervical cancer, significantly higher than those in normal cervical and CIN tissues with statistical difference (P<0.05). P16INK4A positive expression rates of CIN II-III were higher than those of the normal cervical and CIN I tissues (P<0.05). The positive expression rates of Brn-3a and C-myc in normal cervical tissues were 7.1%, significantly lower than those of other groups (P<0.05).The level of telomerase activity in tissues from cervical cancer is (44.38±3.82) U/g, higher than other groups (P<0.05). Conclusion There were abnormal pattern of gene expression of P16INK4A, Brn-3a and C-myc as well as activity of telomerase, likely to be associated with the pathogenesis and development of cervical cancer. The above parameters can be taken as reference indices for the diagnose of cervical cancer.
Related Articles | Metrics
Association between single nucleotide polymorphisms of erythrocyte complement receptor type 1 and the susceptibility of hepatocellular carcinoma

HU Jinchuan, TIAN Yaping, TIAN Weiwei, WEN Xinyu, GAO Yanhong, WANG Ling, DONG Hongfang, LI Yan.

Chinese Clinical Oncology. 2015, 20 (6):  512. 
Abstract ( 771 )   PDF(pc) (877KB) ( 334 )   Save
Objective To investigate the association between single nucleotide polymorphisms (SNP) of erythrocyte complement receptor type 1(CR1) and the susceptibility of hepatocellular carcinoma (HCC). Methods This hospital-based casecontrol study was conducted in 102 cases with HCC (HCC group) and 98 healthy controls (Control group). The plasma samples were collected for the detection of five SNPs (rs4844600 G>A, rs17048010 T>C, rs3818361 C>T, rs11118167 T>C and rs9429945 C>T) of erythrocyte CR1. The intergroup distributional differences comparison of genotypes, alleles and halotypes of SNPs were examined by the overall odds ratio with a 95% confidence interval. Meanwhile, according to gender and age matching principle, 52 and 53 samples were chosen from Control group and HCC group for the measurement of geometric mean fluorescence intensity ratio (GMFIR) of CR1. Results There were significant associations between SNP rs4844600 G>A and the risk for HCC (P<0.01). Compared with control group, the risk of developing HCC of carriers of CR1-rs4844600 G>A/GG genotype increased by 2.458 folds (95%CI: 1.357-4.451) and that of carriers of G allele increased by 1.945 folds (95%CI: 1.183-3.199), while that of carriers of GA genotype decreased by 0.404 folds (95%CI: 0.218-0.746). Other four SNPs including rs17048010 T>C, rs3818361 C>T, rs11118167 T>C and rs9429945 C>T, and haplotypes of rs11118167rs3818361rs17048010 containing TCT, TTC, CCT and TTT were not associatied with the risk for HCC (P>0.05). The GMFIR of CR1 in HCC group was lower than that in control group (3.257±1.191 vs. 2.652±0.789, P<0.01). Conclusion The erythrocyte CR1 level decreases in patients with HCC. SNP rs4844600 G>A of CR1 gene is associated with HCC.
Related Articles | Metrics
Therapeutic effect and prognosis of sorafenib combined with GEMOX regimen in the treatment of advanced hepatocellular carcinoma

LIN Shunhuan, LIU Chun, JIANG Guanming, ZHENG Ruinian.

Chinese Clinical Oncology. 2015, 20 (6):  517. 
Abstract ( 796 )   PDF(pc) (888KB) ( 460 )   Save
Objective To explore the therapeutic effect and safety of sorafenib combined with GEMOX regimen in the treatment of advanced hepatocellular carcinoma (HCC). Methods In a retrospective analysis, 53 HCC patients in our hospital from March 2009 to April 2013 were assigned to receive sorafenib alone (Group A, n=26) or in combination with GEMOX regimen (Group B, n=27). The curative effect was analyzed according to Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1. The National Cancer Institute Common Toxicity Criteria (NCI-CTC) version 3.0 was employed to evaluate the adverse reaction. Survival analysis was performed using KaplanMeier method. Results All the 53 patients were evaluable for evaluation. There were no CR cases in both groups. In Group A, there were 2 cases of PR, 7 cases of SD and 17 cases of PD with the response rate (RR) and disease control rate (DCR) of 7.7% and 34.6%. In Group B, there were 4 cases of PR, 9 cases of SD and 14 cases of PD with RR and DCR of 14.8% and 48.1%. No significant differences were observed between 2 groups (P>0.05). The median progression free survival (PFS) and overall survival (OS) were 4.5 months and 8.4 months in group B, higher than 6.7 and 13.8 months in Group A with statistically significant difference (P<0.05). The main adverse reactions were hand foot syndrome, hypertension and diarrhea in Group A without bone marrow suppression. The most common adverse reactions in group B were bone marrow suppression, manifested as grade 1-2 leukopenia and thrombocytopenia. There were higher incidences of leucopenia, thrombocytopenia and hemoglobin decrease in Group B versus Group A. The major non hematologic toxicity of 2 groups was nausea and vomiting and liver damage. The renal damage, skin rash and peripheral neuritis were rare. Conclusion Sorafenib combined with GEMOX regimen is safe and effective for treatment of advanced HCC and most patients are tolerable. It can bring survival benefit to patients with advanced HCC.
Related Articles | Metrics
Expressions and clinical significance of MTDH and PDCD4 in breast cancer
QV Zhenjie, GUO Weidong, ZHANG Huijie.
Chinese Clinical Oncology. 2015, 20 (6):  521. 
Abstract ( 782 )   PDF(pc) (4044KB) ( 403 )   Save
Objective To explore the expressions of metadherin (MTDH) and programmed cell death 4 (PDCD4) in breast cancer, and analyze their clinicopathological features in breast cancer. Methods The immunohistochemistry SP method was used to detecte the expressions of MTDH and PDCD4 of 65 cases of breast cancer tissues, 30 cases of adjacent normal breast tissues and 30 cases of breast fibroadenoma tissues. The clinicopathological variables of patients of breast cancer were collected and subsequently analyzed for their correlation with expressions of MTDH and PDCD4. Results The positive expression rate of MTDH was 72.3% in breast cancer tissues, higher than 10.0% of adjacent normal breast tissues and 20.0% of breast fibroadenoma tissues (P<0.05), while the positive expression rate of PDCD4 was 41.5% in cancer tissues, lower than 93.3% of adjacent normal breast tissues and 86.7% of breast fibroadenoma tissues (P<0.05). The expression rate of MTDH was related with age, TNM stage and axillary lymph node metastasis but unrelated with tumor size and location. The expression rate of PDCD4 was related with TNM stage and axillary lymph node metastasis but unrelated with age, tumor size and location. The MTDH expression was negatively correlated with PDCD4 (r=-0.595, P<0.05). Conclusion There is high expression of MTDH and low expression of PDCD4 in breast cancer. And they are related with TNM stage and axillary lymph node metastasis, indicating an important role in the occurrence and development of breast cancer.
Related Articles | Metrics
Clinicopathological characteristics and prognosis analysis among 1006 cases of different molecular subtypes of breast cancer in Xinjiang

QIU Xiujuan, LIU Ying, WU Erman, MENG Tao,CHENG Fang.

Chinese Clinical Oncology. 2015, 20 (6):  525. 
Abstract ( 769 )   PDF(pc) (942KB) ( 334 )   Save
Objective To investigate the clinicopathological characteristics and prognosis among different molecular subtypes of breast cancer in Xinjiang.
Methods Clinicopathological characteristics of 1006 cases of operable female breast cancer at Xinjiang Tumor Hospital between January 2008 and December 2010 were analyzed retrospectively. According to status of ER, PR, HER-2 and Ki67, breast cancer patients were divided into Luminal A subtype, Luminal B subtype, HER-2 subtype and Basal-like subtype. The clinical features and prognosis among different molecular subtypes breast cancer were analyzed.
ResultsOut of the 1006 cases, Luminal A subtype, Luminal B subtype, HER-2 subtype and Basal-like subtype took up 54.8%, 18.1%, 7.7%, 19.4%. Only 971 cases had complete follow-up data. Local recurrence rate(12.3%) and distant metastasis rate(27.4%)of HER-2 subtype was significantly higher than other subtypes(P<0.05). The 6-year disease-free survival(DFS) rates of Luminal A subtype, Luminal B subtype, HER-2 subtype and Basallike subtype were 86.8%, 75.8%, 58.9%, 79.1%, and 6-year overall survival rates(OS) were 92.1%, 83.1%, 67.1%, 88.0%. Multivariate analysis revealed that lymph node status, histological grade, endocrine therapy and molecular subtypes were the independent prognostic factors of OS and DFS. Race was the independent prognostic factor of DFS(P<0.05). Conclusion Luminal A is the common subtype of breast cancer in Xinjiang, and its prognosis is the best.The prognosis of HER-2 subtype breast cancer is the worst.Lymph node status, histological grade, endocrine therapy and molecular subtypes may provide important information to predict the prognosis of breast cancer. Race is the independent prognostic factor of DFS.
Related Articles | Metrics
Expression of CTHRC1 and its clinicopathological significance in esophageal squamous cell carcinoma
WANG Hui, XV Qing.
Chinese Clinical Oncology. 2015, 20 (6):  531. 
Abstract ( 783 )   PDF(pc) (931KB) ( 320 )   Save
Objective To explore the clinical significance of CTHRC1 in the development of esophageal squamous cell carcinoma (ESCC). Methods CTHRC1 expression of 215 ESCC cases were detected by tissue microarray and immunohistochemistry. Results The positive rate of CTHRC1 expression was 619%(133/215) in ESCC, while no or weak expression of CTHRC1 was observed in adjacent non-cancerous tissues. There was significant correlation between the expression of CTHRC1 and tumor invasion (P=0.006), lymph node metastasis (P=0.002) and tumor stage (P<0.001). KaplanMeier analysis revealed that patients with CTHRC1 positive expression had a shorter survival time than that without CTHRC1 expression (medican overall survival: 57 months vs. 73 months,P=0.016). CTHRC1 expression was't an independent factor for ESCC according to multivariable regression analysis. Conclusion CTHRC1 was increased with the development and progression of ESCC, indicating CTHRC1 might modulate the development and progression of ESCC.
Related Articles | Metrics
Study on relationship of C-reactive protein with peritoneal cavity metastasis and prognosis of gastric carcinoma
ZHANG Yongjie, ZHU Ziyuan, XUE Yubao, LIU Huaidong, YANG Fei.
Chinese Clinical Oncology. 2015, 20 (6):  535. 
Abstract ( 839 )   PDF(pc) (949KB) ( 444 )   Save
Objective To explore the relationship of C-reactive protein (CRP) with peritoneal cavity metastasis and prognosis of gastric carcinoma. Methods In a retrospective study, the clinic data of 150 patients with advanced gastric carcinoma treated with first-line chemotherapy, including 112 patients with peritoneal cavity metastasis and 38 patients with nonperitoneal cavity metastasis, was analyzed. Influences of CRP, serum albumin, Eastern Cooperative Oncology Group performance status (ECOG PS) and peritoneal cavity metastasis on the prognosis were studied by univariate analysis and Cox proportional hazard mode. The difference of CRP, serum albumin and ECOG was analyzed between patients with or without peritoneal cavity metastasis. Results The results of univariate analysis showed that the factors associated with poor prognosis were CRP, serum albumin, ECOG and peritoneal cavity metastasis. According to multivariate analysis, peritoneal cavity metastasis was the only factor independently associated with prognosis. Compared with nonperitoneal cavity metastasis group, CRP (P=0.006) and ECOG PS (P<0.001) were significantly increased, while serum albumin group(P<0.001) was significantly decreased in peritoneal cavity metastasis group(P<0.001). Conclusion Compared with non-peritoneal cavity metastasis group, response of systemic inflammation was significantly upregulated in peritoneal cavity metastasis group with poorer prognosis, which could provide a treatment strategy for advanced gastric carcinoma patients with peritoneal cavity metastasis from standpoint of inflammation.
Related Articles | Metrics
临床应用
Clinical observation of argonhelium knife cryotherapy combined with transcatheter arterial chemoembolization (TACE) on huge liver cancer
QIU Guoqin, XU Lizhen, LUO Pengfei, CHEN Yuqiang.
Chinese Clinical Oncology. 2015, 20 (6):  540. 
Abstract ( 630 )   PDF(pc) (869KB) ( 338 )   Save
Objective To explore the efficacy and safety of argon-helium knife cryotherapy combined with transcatheter arterial chemoembolization (TACE) on huge hepatocellular carcinoma. Methods Eighty-five patients with huge liver cancer from September 2006 to August 2011 were analyzed retrospectively. Observation group (n=44) received one to two TACE and one to three argonhelium knife cryotherapy after one month sequently, while the control group (n=41) received TACE treatment only. Response to chemotherapy was assessed by RECIST criteria 1.0 and follow-up data was investigated. Results The response rate of observation group was 70.5%, higher than 46.3% of the control group (P<0.05). The 1-, 2-, 3-year survival rates of observation group were 77.3%, 56.8% and 36.4%, and medium overall survival time was 19.2 months, which were all higher than the 51.2%, 36.6%, 14.6% and 11.8 months of control group (P<0.05). The adverse reaction of both groups were mild-to-moderate and tolerable. Conclusion Argon-helium knife cryotherapy combined with TACE has synergism effect and minimally invasive, and provide a new regiem for comprehensive treatment on huge hepatocellular carcinoma.
Related Articles | Metrics
Clinicopathological analysis of childhood embryonal rhabdomyosarcoma in Xinjiang
SONG Xinlan, FU Juanjuan.
Chinese Clinical Oncology. 2015, 20 (6):  545. 
Abstract ( 739 )   Save
Objective To analyze the clinicopathological and immunohistochemical characteristics of pediatric embryonal rhabdomyosarcoma (ERMS) in Xinjiang. Methods In this retrospective study, the clinical data and immunological phenotype of 20 cases of childhood ERMS were analyzed.
ResultsThere were 11 male and 9 female patients with ages ranging from 10 months to 18 years (mean age: 6.4 years), among which 85.0% occur in children under the age of 10. There were 5 cases of the Han nationality, 12 cases of the Uyghur nationality and 3 cases of other ethnic nationalities. The primary sites were found in head and neck (10 cases), extremities (3 cases), genitourinary system (3 cases), trunk (2 cases), lung (1 case) and pelvic (1 case) region. Clinical symptoms varied widely, based on the location of the primary tumor. There was one case of botryoid rhabdomyosarcoma among 20 ERMS. The positive staining rates for Vimentin, Desmin, MyoD1, Myogenin and CD99 were 100.0%, 90.0%, 55.0%, 90.0% and 50.0%, respectively. Conclusion ERMS was malepredominant and more common among children under 10 years old. It mainly occurs in head and neck region. The clinical manifestation is different depending on the different regions. The incidence of the minority nationality was significantly higher than that of the Han nationality. Morphology and immunohistochemical staining are very useful in the diagnosis of ERMS.
Related Articles | Metrics
综述与讲座
Diagnosis and treatment for gastric neuroendocrine tumors

LIU Dan, SHEN Lin, LU Ming.

Chinese Clinical Oncology. 2015, 20 (6):  549. 
Abstract ( 728 )   PDF(pc) (925KB) ( 729 )   Save
Gastric neuroendocrine tumors(G-NETs) arise in enterochromaffin-like(ECL) cells, which only account for a small part of gastric tumors. People have been less focused on them, so that the diagnosis and treatment of G-NETs are lack of acknowledged guidelines. However, with the increasing incidence, there is more deeply acknowledge in this field. In clinical, G-NETs are compromised of 4 subtypes according to differentiation and the relationship with hypergastrinemia. In the current review, we summarize the pathology, clinical characteristics, which aimed at treatment of it.
Related Articles | Metrics
Progression on the roles of E-cadherin in invasion and metastasis of gastric cancer
XUE Song, CHEN Yingxia.
Chinese Clinical Oncology. 2015, 20 (6):  555. 
Abstract ( 735 )   Save
Invasion and metastasis are the basic characteristic of gastric cancer, and as well as the main cause of death in gastric cancer patients. Epithelial cadherin(E-cadherin) plays an important role in the oncogenesis and development of gastric cancer. The decreased expression of E-cadherin can induce epithelial-mesenchymal transition(EMT).So it is very significant for the further study on the relationship between E-cadherin and gastric cancer. It may provide a new theoretical basis for the treatment of gastric cancer. In this paper, we review the progression in E-cadherin for the invasion and metastasis of gastric cancer.
Related Articles | Metrics
Progression on prevention and treatment of olanzapine in chemotherapyinduced nausea and vomiting
ZHOU Dongai,YI Jun,MA Jin'an.
Chinese Clinical Oncology. 2015, 20 (6):  559. 
Abstract ( 781 )   Save
Chemotherapyinduced nausea and vomiting is the most common gastrointestinal reaction of chemotherapy side effects, and also one of the important influential factors in chemotherapy compliance within tumor patients. Olanzapine is a widely-used atypical antipsychotics in psychiatric clinical pratice, which also has a ability to block many different antiemetic properties ossociated receptors. In recent years, olanzapine has been approved effectively in the prevention and treatment of chemotherapyinduced nausea and vomiting, with little adverse reaction and good tolerance. This paper summarizes the clnical progression on prevention and treatment of olanzapine in chemotherapy induced nausea and vomiting.
Related Articles | Metrics
Progression on moleculartargeted therapy of radioiodinerefractory differentiated thyroid cancer
LIU Min, CHEN Libo.
Chinese Clinical Oncology. 2015, 20 (6):  564. 
Abstract ( 728 )   Save
There is no standard therapy for radioiodinerefractory differentiated thyroid cancer which do not respond to traditional therapies. Recently, a number of genetic alterations have been described in thyroid cancer, which provides an unprecedented opportunity for the identification of novel diagnostic and prognostic molecular markers as well as novel therapeutic targets. Novel molecular-targeted treatments hold great promise for radioiodine-refractory and surgically inoperable thyroid cancer as shown in the most recent clinical trials and meta-analysis. This review is to outline the modern thyroid cancer medicine from a clinical perspective, focusing on the latest advances in molecular-targeted therapy.
Related Articles | Metrics
Treatment progress of primary vaginal cancer
CHEN Jiao, KONG Weimin.
Chinese Clinical Oncology. 2015, 20 (6):  568. 
Abstract ( 555 )   Save
Primary vaginal cancer is very rare, accounting for about 1% to 2% of all neoplasm of the female genitals. Given to its rarity, there is no large sample prospective study, and the standard treatment pattern for primary vaginal cancer is still undefined. The treatment methods, including surgery, radiation therapy, chemotherapy and comprehensive therapy, refers to the therapy of cervical and vulva cancer. It emphasizes on individualization. This article aims to sum up the related studies of treatment for primary vaginal cancer in recent years, including the using of laparoscopic technique in vaginal cancer surgery, vagina reconstruction after surgery and the using of three-dimension radiotherapy and radiochemotherapy as to provide reference for the treatment of primary vaginal cancer.
Related Articles | Metrics